热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
FITC anti-mouse CD4 Antibody
产品名称：
FITC anti-mouse CD4 Antibody
产品类别：
抗体
产品编号：
100405
产品应用：
100405
[价格]
规格 价格 库存
50µg ￥ 360 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse CTL clone V4
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The CD4 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Additional reported applications (for the relevant formats) include: blocking of CD4+ T cell activation1,4,11, thymocyte costimulation3, in vitro and in vivo depletion2,5-8, blocking of egg-sperm cell adhesion1,4, immunohistochemical staining of acetone-fixed frozen sections9,10, immunoprecipitation1,2, and spatial biology (IBEX)12,13. The GK1.5 antibody is able to block CD4 mediated cell adhesion and T cell activation.?Binding of GK1.5 antibody to CD4 T cells can be blocked by RM4-5 antibody, but not RM4-4 antibody. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF? purified antibody (Cat. No. 100442) with a lower endotoxin limit than standard LEAF? purified antibodies (Endotoxin < 0.01 EU/?g).

Application References

(PubMed link indicates BioLegend citation)
  1. Dialynas DP, et al. 1983. J. Immunol. 131:2445. (Block, IP)
  2. Dialynas DP, et al. 1983. Immunol. Rev. 74:29. (IP, Deplete)
  3. Wu L, et al. 1991. J. Exp. Med. 174:1617. (Costim)
  4. Godfrey DI, et al. 1994. J. Immunol. 152:4783. (Block)
  5. Gavett SH, et al. 1994. Am. J. Respir. Cell. Mol. Biol. 10:587. (Deplete)
  6. Schuyler M, et al. 1994. Am. J. Respir. Crit. Care Med. 149:1286. (Deplete)
  7. Ghobrial RR, et al. 1989. Clin. Immunol. Immunopathol. 52:486. (Deplete)
  8. Israelski DM, et al. 1989. J. Immunol. 142:954. (Deplete)
  9. Zheng B, et al. 1996. J. Exp. Med. 184:1083. (IHC)
  10. Frei K, et al. 1997. J. Exp. Med. 185:2177. (IHC)
  11. Felix NJ, et al. 2007. Nat. Immunol. 8:388. (Block)
  12. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  13. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Chuang H, et al. 2014. Nat Commun. 5:4602. PubMed
  2. Chang YS, et al. 2020. Int J Mol Sci. 21:00. PubMed
  3. Djokić V, et al. 2019. Front Immunol. 9:2891. PubMed
  4. Katsumura KR, et al. 2018. Proc Natl Acad Sci U S A. 115:E10109. PubMed
  5. Valanparambil RM, et al. 2017. PLoS Pathog. 13:e1006647. PubMed
  6. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  7. Zhao J, et al. 2021. Emerg Microbes Infect. 10:913. PubMed
  8. Liu J, et al. 2021. Front Immunol. 12:747730. PubMed
  9. Su Y, et al. 2022. J Hematol Oncol. 15:99. PubMed
  10. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  11. Zelenka T, et al. 2022. Nat Commun. 13:6954. PubMed
  12. Rosenkranz SC, et al. 2021. eLife. 10:00. PubMed
  13. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  14. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  15. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  16. Yang Z, et al. 2022. J Immunother Cancer. 10:. PubMed
  17. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  18. Sch?nberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  19. He R, et al. 2021. J Immunol. 206:2353. PubMed
  20. Ma J, et al. 2020. Adv Sci (Weinh). 7:2000609. PubMed
  21. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  22. Sega E, et al. 2008. Int J Radiat Oncol Biol Phys. 71:559. PubMed
  23. Lua Y, et al. 2012. Mol Immunol. 52:229. PubMed
  24. Zas?ona Z, et al. 2014. J Immunol. 193:4245. PubMed
  25. Aguilera T, et al. 2016. Nat Commun. 7:13898. PubMed
  26. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  27. Yang F, et al. 2021. Front Microbiol. 11:512581. PubMed
  28. Luo R, et al. 2021. Theranostics. 11:117. PubMed
  29. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  30. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  31. Jiang W, et al. 2022. Front Immunol. 13:878832. PubMed
  32. Toomer G, et al. 2022. Viruses. 14:. PubMed
  33. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  34. Altshuler A, et al. 2021. Cell Stem Cell. 28(7):1248-1261.e8. PubMed
  35. Tang Y, et al. 2020. Front Immunol. 11:585918. PubMed
  36. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  37. Pobezinskaya EL et al. 2019. Front Immunol. 1.079861111 . PubMed
  38. Choi H et al. 2019. Cell Rep. 27(3):806-819 . PubMed
  39. Liang Q, et al. 2022. iScience. 25:104043. PubMed
  40. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  41. Bangs DJ, et al. 2022. Cell Rep. 38:110266. PubMed
  42. Jazowiecka-Rakus J, et al. 2021. Cancers (Basel). 13:. PubMed
  43. Chen J, et al. 2022. J Nanobiotechnology. 20:283. PubMed
  44. Wu M, et al. 2021. Nat Commun. 12:3500. PubMed
  45. Guan H, et al. 2012. PLoS One. 7:e35650. PubMed
  46. D Kim, S Lee, H Jun 2016. Immunol Cell Biol. 10.1038/icb.2016.98. PubMed
  47. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  48. Molina-Sanchez P, et al. 2020. Gastroenterology. 2203:159. PubMed
  49. Qi X, et al. 2019. Nat Commun. 10:2141. PubMed
  50. Wu J, et al. 2020. Sci Adv. 6:eaba3458. PubMed
  51. Aqel SI, et al. 2021. JCI Insight. 6:e142376. PubMed
  52. Hu D, et al. 2021. J Cell Mol Med. 25:2900. PubMed
  53. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  54. Wang Y, et al. 2022. Acta Pharm Sin B. 12:262. PubMed
  55. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
  56. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  57. Mardomi A, et al. 2021. J Cell Physiol. 236:6328. PubMed
  58. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  59. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  60. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  61. White C, et al. 2014. J Immunol. 193:5933. PubMed
  62. Sarapulov AV, et al. 2020. Front Immunol. 11:599. PubMed
  63. Thomas S, et al. 2019. J Immunother Cancer. 7:214. PubMed
  64. Tritama E, et al. 2018. Hum Vaccin Immunother. 14:1524. PubMed
  65. Mauduit O, et al. 2022. Front Immunol. 13:1011125. PubMed
  66. Liu Y, et al. 2022. Nat Commun. 13:2665. PubMed
  67. Anastasiou M, et al. 2021. JCI Insight. 6:. PubMed
  68. Li H, et al. 2021. Nat Commun. 12:2773. PubMed
  69. Ma X, et al. 2021. Cell Metabolism. 33(5):1001-1012.e5. PubMed
  70. Zongyi Y, et al. 2017. PLoS One. 10.1371/journal.pone.0189617. PubMed
  71. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  72. Edwards CJ, et al. 2021. Br J Cancer. . PubMed
  73. Jing L, et al. 2022. Front Immunol. 13:864995. PubMed
  74. Feng H, et al. 2020. J Dermatol. 47:147. PubMed
  75. Ren HZ, et al. 2022. J Clin Transl Hepatol. 10:1138. PubMed
  76. Wang Z, et al. 2020. J Clin Invest. 130:3717. PubMed
  77. Pedraza–Zamora CP, et al. 2017. Parasite Immunol. 39:4. PubMed
  78. Raineri D, et al. 2021. Biomedicines. 10:. PubMed
  79. He X, et al. 2021. Small. 17:e2007165. PubMed
  80. Katsinas N, et al. 2022. J Clin Med. 11:. PubMed
  81. He X, et al. 2021. Adv Sci (Weinh). 8:e2103023. PubMed
  82. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  83. Vigeland C, et al. 2016. PLoS One. 11: 0163288. PubMed
  84. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  85. Deng Z, et al. 2020. World J Gastrointest Oncol. 1091:12. PubMed
  86. Zhang W, et al. 2019. Oncol Lett. 17:815. PubMed
  87. Cervera–Carrascon V, et al. 2020. Oncoimmunology. 9:1761229. PubMed
  88. Paul S, et al. 2018. Appl Microbiol Biotechnol. 102:8895. PubMed
  89. Cheng B, et al. 2022. Cancer Commun (Lond). 42:17. PubMed
  90. Wang Z, et al. 2022. Nat Biomed Eng. 6:791. PubMed
  91. Guo P, et al. 2021. J Immunol. 207:408. PubMed
  92. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  93. Knocke S, et al. 2016. Cell Rep. 17:2234-2246. PubMed
  94. Ahmari N, et al. 2016. Physiol Genomics. 48: 526 - 536. PubMed
  95. Ito C, et al. 2015. PLoS One. 10: e0140808. PubMed
  96. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  97. Kim JH, et al. 2019. Mol Med. 25:33. PubMed
  98. Niknam S, et al. 2018. Clin Cancer Res. 24:5735. PubMed
  99. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  100. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  101. Zhou H, et al. 2022. Oncoimmunology. 11:2057892. PubMed
  102. He X, et al. 2022. Cancer Immunol Res. 10:314. PubMed
  103. Hum NR, et al. 2022. Front Oncol. 12:928474. PubMed
  104. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  105. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  106. Zhang Y, et al. 2021. J Immunol Res. 2021:5599439. PubMed
  107. Uddback I, et al. 2016. Sci Rep. 6:20137. PubMed
  108. Toomer K, et al. 2016. J Immunol. 196: 3665 - 3676. PubMed
  109. Faust HJ, et al. 2020. J Clin Invest. 130:5493. PubMed
  110. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  111. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  112. Haas MS, et al. 2020. Mol Cancer Res. 19:717. PubMed
  113. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  114. Wang Y, et al. 2021. Front Microbiol. 12:701566. PubMed
  115. Gebre MS, et al. 2022. NPJ Vaccines. 7:88. PubMed
  116. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  117. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  118. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  119. Mencl S, et al. 2014. J Neuroimmunol. 274:125. PubMed
  120. Zhou J, et al. 2019. Nat Commun. 10:2427. PubMed
  121. Sun H, et al. 2022. Front Immunol. 13:818017. PubMed
  122. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  123. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  124. Lang V, et al. 2021. Elife. 10:. PubMed
  125. Peng L, et al. 2022. Cell Rep Med. 3:100634. PubMed
  126. Huang L, et al. 2021. Breast Cancer Res Treat. Online ahead of print. PubMed
  127. Lu J, et al. 2021. Cell Death Discov. 7:165. PubMed
  128. Han F, et al. 2020. Invest Ophthalmol Vis Sci. 61:24. PubMed
  129. Kmieciak M, et al. 2011. J Vis Exp. 47: 2381. PubMed
  130. Li Y, Kaneda T 2016. Sci Rep. 6: 25077. PubMed
  131. Timilshina M, et al. 2017. PLoS One. 10.1371/journal.pone.0168942. PubMed
  132. Wang X, et al. 2020. Nat Commun. 4.505555556. PubMed
  133. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  134. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  135. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  136. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  137. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  138. Guo S, et al. 2021. Sci Rep. 11:23745. PubMed
  139. Ma K, et al. 2022. iScience. 25:104347. PubMed
  140. Li J, et al. 2022. Nat Commun. 13:4032. PubMed
  141. Gao X, et al. 2022. Front Immunol. 13:799331. PubMed
  142. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  143. Liu Y, et al. 2020. Oncol Lett. 2369:20. PubMed
  144. Martomo SA, et al. 2021. Mol Cancer Ther. 1.074305556. PubMed
  145. Zan H, et al. 2017. Nat Commun. 8:14244. PubMed
  146. Kamata T, et al. 2020. Cell Reports. 31(12):107802. PubMed
  147. Ouyang S, et al. 2019. J Immunol. 202:1441. PubMed
  148. Reynolds CJ, et al. 2018. Sci Rep. 8:672. PubMed
  149. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  150. He C, et al. 2022. Nat Commun. 13:5459. PubMed
  151. Takaku S, et al. 2022. Evid Based Complement Alternat Med. 2022:6122955. PubMed
  152. Zhang S, et al. 2022. Nat Commun. 13:4744. PubMed
  153. Yuan M, et al. 2022. Oxid Med Cell Longev. 2022:5479491. PubMed
  154. Li J, et al. 2020. Development. . PubMed
  155. Shibuya M, et al. 2021. iScience. 24:103131. PubMed
  156. Nasarre P, et al. 2021. Cancers (Basel). 13: . PubMed
  157. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  158. Ligon MM, et al. 2020. Mucosal Immunol. 1.172222222. PubMed
  159. Da Mesquita S, et al. 2021. Science Advances. 7(21):. PubMed
  160. Wedekind MF, et al. 2021. iScience. 24(7):102759. PubMed
  161. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  162. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  163. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  164. Yao C, et al. 2018. Autophagy. 1.854861111. PubMed
  165. Zhang Q, et al. 2022. Commun Biol. 5:544. PubMed
  166. Jazowiecka-Rakus J, et al. 2020. Mol Ther Oncolytics. 18:335. PubMed
  167. Soria-Castro R, et al. 2020. Sci Rep. 10:17802. PubMed
  168. Chen H, et al. 2022. Front Pharmacol. 13:827520. PubMed
  169. Karanika S, et al. 2022. Front Immunol. 13:972266. PubMed
  170. Si J, et al. 2020. Cancer Cell. 38(4):551-566.e11. PubMed
  171. Khosravi N, et al. 2018. Cancer Immunol Res. 0.797222222. PubMed
  172. Kos S, et al. 2019. PLoS One. 14:e0217762. PubMed
  173. Ji L et al. 2019. Immunity. 51(2):272-284 . PubMed
  174. Habtetsion T et al. 2018. Cell metabolism. 28(2):228-242 . PubMed
  175. Coley WD et al. 2018. F1000Research. 2018 Mar 14 [revised 2018 Jan 1] 0.5125. PubMed
  176. Pan L, et al. 2022. Front Immunol. 13:837497. PubMed
  177. Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
  178. He X, et al. 2021. J Immunother Cancer. 9:. PubMed
  179. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  180. Liu Y, et al. 2020. Cell Death Dis. 11:1062. PubMed
  181. Bryan Hart, Sunhee Lee 2016. PLoS Negl Trop Dis. 10:e0005229. PubMed
  182. Blaszczak AM, et al. 2020. Immunometabolism. 2:00. PubMed
  183. Yang C, et al. 2020. Cell Host Microbe. 467:27. PubMed
  184. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  185. Sivapatham S, et al. 2019. Front Immunol. 1.865277778. PubMed
  186. Zhao Y, et al. 2020. Front Immunol. 2.572222222. PubMed
  187. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  188. Zhong C, et al. 2021. J Virol. 95:e0092521. PubMed
  189. Magee JA, et al. 2021. Stem Cell Reports. 16:20. PubMed
  190. Xu Y, et al. 2021. iScience. 24:103445. PubMed
  191. Zhou S, et al. 2021. Adv Funct Mater. 31:. PubMed
  192. Smith KJ, et al. 2022. PLoS Biol. 20:e3001554. PubMed
  193. Sears SM, et al. 2022. Kidney360. 3:818. PubMed
  194. Aguilera TA, et al. 2020. Clin Cancer Res. 26:2972. PubMed
  195. Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed
  196. Hart B, et al. 2015. PLoS Negl Trop Dis. 9: 0004046. PubMed
  197. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  198. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  199. Blaszczak AM, et al. 2019. J Immunol. 202:2451. PubMed
  200. Liang Z, et al. 2017. Autophagy. 14:505. PubMed
  201. Nakao R, et al. 2022. NPJ Vaccines. 7:153. PubMed
  202. Wang Y, et al. 2022. Nat Commun. 13:1454. PubMed
  203. Barsoumian HB, et al. 2022. Cancers (Basel). 14:. PubMed
  204. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  205. Li Z, et al. 2022. Evid Based Complement Alternat Med. 2022:7421265. PubMed
  206. Yue T, et al. 2022. Cell Death Differ. 29:218. PubMed
  207. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  208. Gardenier J, et al. 2017. Nat Commun. 8:14345. PubMed
  209. Jaeger N, et al. 2020. Cell Rep. 33:108331. PubMed
  210. Zeng A, et al. 2020. Oncol Rep. . PubMed
  211. Bartley A, et al. 2018. Front Physiol. 9:1593. PubMed
  212. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  213. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  214. Hsu HP, et al. 2021. J Biol Chem. 296:100419. PubMed
  215. Zhang M, et al. 2022. iScience. 25:104490. PubMed
  216. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  217. Rodrigues KA, et al. 2021. Sci Adv. 7:eabj6538. PubMed
  218. Kathania M, et al. 2022. Cell Rep. 40:111345. PubMed
  219. Gawish R, et al. 2022. Elife. 11:. PubMed
  220. Li J, et al. 2022. Nat Commun. 13:1481. PubMed
  221. Guo S, et al. 2021. Frontiers in Immunology. 11:614667. PubMed
  222. Cortez MA, et al. 2020. Nat Commun. 3.819444444. PubMed
  223. Zhou T, et al. 2018. Mol Med Rep. 17:4883. PubMed
  224. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  225. Liang Z, et al. 2022. iScience. 25:105233. PubMed
  226. Lestari SR, et al. 2020. J Ayurveda Integr Med. 11:414. PubMed
  227. Jiang W, et al. 2021. Cell Rep. 37:110112. PubMed
  228. Chang MH, et al. 2021. Cell Rep. 37:109902. PubMed
  229. Ding X, et al. 2021. Front Immunol. 12:667136. PubMed
RRID
AB_312690 (BioLegend Cat. No. 100405) AB_312691 (BioLegend Cat. No. 100406)

Antigen Details

Structure
Ig superfamily, 55 kD
Distribution

Majority of thymocytes, T cell subset

Function
TCR co-receptor, T cell activation
Ligand/Receptor
MHC class II molecule
Cell Type
Dendritic cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Bierer BE, et al. 1989. Annu. Rev. Immunol. 7:579.
3. Janeway CA. 1992. Annu. Rev. Immunol. 10:645.

Gene ID
12504 View all products for this Gene ID
UniProt
View information about CD4 on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线